Oct 14, 2026, 01:51 UTC
Japanese stocks and a listed fund appeared in Kabutan’s 10:30 trading-volume-change ranking, with reported share-price moves ranging from a 6.89% decline for Daikokutenbussan to a 6.84% gain for Geomatec.
Source:Oct 13, 2026, 09:06 UTC
Cosmos Pharmaceutical opened 13 stores during June–August, including two in Tohoku, four in Kanto and three in Chubu.
Source:Oct 13, 2026, 09:06 UTC
Cosmos Pharmaceutical reported consolidated net profit of ¥8.2 billion, up 1% year over year, and sales of ¥286.6 billion, up 5%, for June–August 2026.
Source:Oct 2, 2026, 02:30 UTC
Cosmos Pharmaceutical reported a 16% increase in operating profit for June-August and continued same-store sales growth in September.
Source:Jul 13, 2026, 09:11 UTC
Cosmos Pharmaceutical announced on July 13, 2026 that it will open 120 new stores by the fiscal year ending May 2027, including entry into Nagano and Fukushima prefectures.
Source:Jul 13, 2026, 06:30 UTC
Cosmos Pharmaceutical increased its annual dividend for the prior fiscal year from 75 yen to 82 yen, and announced a planned increase to 84 yen for the current fiscal year.
Source:Jul 13, 2026, 06:30 UTC
Cosmos Pharmaceutical reported its full-year results for the fiscal year ended May 2026, showing a 3.4% increase in recurring profit to 44.6 billion yen, and issued guidance for the fiscal year ending May 2027 with a 2.4% increase to 45.7 billion yen, marking a third consecutive record high.